Our laboratory has previously developed cell lines derived from mouse NIH 3T3 fibroblasts and C127 mammary tumor cells that stably express mouse mammary tumor virus (MMTV) long terminal repeat fusion genes in bovine papillomavirus-based episomes. Glucocorticoid hormone strongly activates transcription from episomes and induces the disruption of a single nucleosome in an array of phased nucleosomes on the MMTV promoter. Sodium butyrate inhibits the glucocorticoid hormone-dependent development of a nuclease-hypersensitive site that is due to the displacement of this nucleosome, and inhibits induction of RNA transcripts from episomes. Saturation binding studies show that butyrate treatment does not significantly affect the amount or the hormone-binding affinity of the glucocorticoid receptor. In a transient transfection assay, glucocorticoid hormone can activate transcription from a MMTV long terminal repeat-driven luciferase gene construct equivalently in untreated and butyrate-treated cells, indicating that the soluble factors necessary for transactivation of the MMTV promoter are unaffected by butyrate. The differential effect of butyrate on the induction of stable chromatin templates and transiently expressed plasmids suggests that butyrate prevents nucleosome displacement and represses transcription by inducing a modification of chromatin.
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The organization ofgenes into nucleosomes and higher-order chromatin structure has important implications for transcriptional regulation (for reviews see refs. [1] [2] [3] [4] . One example of this functional role of chromatin is illustrated by the regulation of mouse mammary tumor virus (MMTV) transcription by glucocorticoid hormone. A phased array of six nucleosomes is positioned on the MMTV long terminal repeat (LTR) in bovine papillomavirus (BPV)-based episomes (5) and single integrated copies (6) . As an early step in the activation of the MMTV promoter by glucocorticoid hormone, the hormone-activated glucocorticoid receptor binds to glucocorticoid regulatory elements (GREs) on one of these nucleosomes (Nuc-B), initiating a process whereby Nuc-B is displaced (see Fig. 1 ). In vivo exonuclease III footprinting experiments have demonstrated that a consequence of this receptor-dependent chromatin reorganization is the binding of the transcription factors NF1 and TFIID to their cognate recognition sites on the MMTV promoter (7) . As the apparent concentrations and specific DNA-binding activities of NF1 and TFIID are identical in extracts from hormone-treated and untreated cells (8) , it has been proposed that these factors are excluded from their recognition sites by the specific positioning of Nuc-B (9) .
The disruption of precisely positioned nucleosomes has been shown to occur in several other systems during transcriptional activation in vivo. A yeast acid phosphatase gene (PHOS) has an array of phased nucleosomes covering its promoter when it is repressed by high Pi (10, 11 (14) . These results support a general model in which the positioning of nucleosomes on regulatory regions of genes restricts access of transcription factors.
In vitro transcription experiments have provided results consistent with the hypothesis that chromatin represses transcription by regulating access of RNA polymerase and/ or transcription factors. By using DNA restriction fragments of defined length that are reconstituted with nucleosomes, it has been shown that the assembly of naked DNA into chromatin inhibits transcription initiation by RNA polymerases II and III (15) (16) (17) (18) (19) (20) . One approach has been to examine the transcriptional activity of chromatin templates assembled in vitro in the presence or absence of transcription factors. Workman and Roeder (17) demonstrated that the binding of TFIID to the adenovirus major late promoter prevented transcriptional repression during subsequent nucleosome assembly. In addition, Knezetic and Luse (15) showed that when DNA templates containing the adenovirus major late promoter were reconstituted with nucleosomes, transcription initiation was inhibited. Assembly of preinitiation complexes on DNA templates prior to nucleosome assembly resulted in efficient transcription initiation (16) . One difficulty in interpreting these results is that the precise positions of reconstituted nucleosomes with respect to DNA regulatory regions have not been established. Since the positioning of nucleosomes on or near DNA regulatory regions prevents transcription initiation, some mechanism must exist in vivo to disrupt such nucleosomes in response to an appropriate environmental signal.
It is of obvious importance to define the signals and factors that target specific nucleosomes for disruption and, in a more general manner, to understand the impact of nucleosome phasing and stability on the interaction of transcription factors with chromatin templates. It is generally believed that Abbreviations: BPV, bovine papillomavirus; GRE, glucocorticoid regulatory elements; LTR, long terminal repeat; MMTV, mouse mammary tumor virus; Nuc-B, nucleosome B; SV40, simian virus 40; TA, triamcinolone acetonide; t antigen, small tumor antigen.
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nucleosomes are assembled and disassembled in a DNA replication-dependent manner (21) . In the case of the MMTV LTR, however, glucocorticoid induction of Nuc-B disruption occurs under conditions in which 95% of DNA synthesis is inhibited (6) , suggesting that a DNA replication-independent mechanism of nucleosome disruption must exist. As histones are subject to posttranslational modifications-e.g., acetylation of lysine residues (22)-it is possible that these modifications may be involved in DNA replication-independent nucleosome structural transitions or even displacement.
Separation of chromatin into fractions with varying degrees of transcriptional activity has revealed correlations between histone hyperacetylation and transcriptionally active chromatin (23) (24) (25) . To investigate the effect of histone acetylation or deacetylation on hormone-dependent disruption of Nuc-B on the MMTV promoter, we used butyrate, a short-chain fatty acid that induces histone hyperacetylation by directly inhibiting histone deacetylase (26, 27 (7, 28, 29 (31) and was obtained from S. Nordeen (University of Colorado Health Sciences Center, Denver). Plasmid pLTR-luc has the entire MMTV LTR linked to a luciferase reporter gene (see Fig. 1B ; P.L. and G.L.H., unpublished data).
Endonuclease Hypersensitivity Assay. Nuclei were isolated from 5 x 107 cells that had been treated as described in the figure legends. Washed nuclei were resuspended (107 per 0.1 ml) in Sst I or DNase I digestion buffer and incubated for 15 min at 30°C with or without Sst I (50-100 units/0.1 ml) or DNase I (4-12 units/0.1 ml). Reactions were terminated by adding 5 volumes of 0.1 M Tris'HCl (pH 7.4) containing 10 mM EDTA, 0.5 mg of proteinase K per ml, and 1% Nlauroylsarcosine and were incubated for at least 5 hr at 37°C. Genomic DNA was purified by multiple extractions with phenol and chloroform.
Northern and Southern Blot Analysis. Total cytoplasmic RNA was extracted by lysing cells in 200 mM TrisHCl, pH 7.4/140 mM NaCl/2 mM MgCl2/0.5% Nonidet P-40. After nuclei were removed by centrifugation, the extract was adjusted to 0.1% SDS and 5 mM EDTA. RNA was purified by extraction twice with phenol/chloroform and twice with chloroform, followed by ethanol precipitation. RNA was resolved in 1.5% agarose/formaldehyde gels, transferred to Nytran (Schleicher & Schuell) nylon membranes, and hybridized with 32P-labeled v-Ha-ras or ,3-actin probes. DNA was resolved in 1.5% agarose gels in Tris acetate buffer, transferred to Nytran membranes, and hybridized with a 32P-labeled MMTV LTR probe.
Transient Transfection Assay. pRSV-luc and pLTR-luc were transfected into 904.13 cells by the calcium-phosphate method (32) . Cell lysates were prepared, and luciferase assays were performed exactly as described (30 (28) contains the ras oncogene driven by the MMTV LTR, and the transforming 69'% fragment of BPV. The LTR promoter is in the same transcriptional orientation as the promoter in the BPV fragment. Wide solid lines indicate short regions (650 base pairs) of pBR322 DNA retained in the episomes. pm23 contains a similar LTR-ras cassette, except that transcription is in the opposite sense relative to BPV, and a DNA segment containing the t-antigen splice signals and early polyadenylylation site from SV40 is included. Features of this cassette, including the position of nucleosomes A-F on the MMTV LTR and the location of the ras protein (p21)-coding region are shown in the detail above pm23. Nuc-B is displaced during transcription activation (5) . The spliced LTR transcript from pm23 is predicted to be 3.1 kilobases long. cat, Residual sequences from chloramphenicol acetyltransferase reading frame,; 30s, rat retroviral-related sequences. (B) Luciferase transient-expression vector. The same t-antigen splice signals and polyadenylylation Sitare present downstream of the luciferase coding region. Two additional copies of the poly(A) site are present immediately upstream of the LTR to minimize expression of the luciferase gene from inappropriate initiation events in plasmid DNA (30) . start site) that is hypersensitive to the restriction enzyme Sst I (9). This site lies within the broad hormone-inducible DNase I-, micrococcal nuclease-, and (methidiumpropyl-EDTA)Fe(II)-hypersensitive site (-60 to -250) that has been mapped by indirect end labeling (5) . In this study, we asked whether the development of this hypersensitive site is affected under conditions in which butyrate induces histone hyperacetylation.
Cells (904.13) were treated with butyrate for 12 hr, followed by TA for 1 hr. Nuclei were isolated and subjected to a limited digestion with Sst I or DNase I. Genomic DNA was purified, digested to completion with Ava I, and analyzed by Southern blotting with a MMTV LTR probe. A strong hormone-dependent induction of Sst I and DNase I hypersensitivity was observed (Fig. 2) , in agreement with earlier observations (5, 6, 9) . In contrast, pretreatment of cells with butyrate for 12 hr resulted in complete inhibition of the development of hypersensitivity. A similar result was observed with 1361.5 cells (derived from NIH 3T3 cells and expressing the pm23 episome), demonstrating that the effect is independent of the cell type and vector (data not shown). SDS/PAGE and fluorography of sulfuric acid-extracted histones from cells labeled with [3H]acetic acid revealed that the extent of labeling was much greater for histones (primarily histones H3 and H2A) from butyrate-treated cells compared to control cells (data not shown). Since induction of the hypersensitive site arises from the disruption of Nuc-B (5), these data suggest that under conditions in which butyrate induces global histone hyperacetylation, Nuc-B is incompetent to undergo displacement.
Butyrate Inhibits Glucocorticoid Induction of RNA Transcripts from Episomes. Considering that the hormone-induced endonuclease-hypersensitive site on the MMTV promoter is believed to be necessary for transcriptional activation, we examined the effect of butyrate on the induction of RNA transcripts from episomes. Cells were treated with 10 mM butyrate for 2, 8, or 24 hr, followed by TA for 4 hr in the continued presence of butyrate. Total cytoplasmic RNA was analyzed by Northern blot analysis with a v-Ha-ras probe. Multiple transcripts were detected after hormone treatment (Fig. 3) . Heterogeneity of RNA transcripts arises from the lack of a polyadenylylation signal in the pM18 construct that is stably expressed in 904.13 cells. There was substantial inhibition of the induction of these transcripts by 2 hr and essentially complete inhibition by 24 hr. The rapidity of this inhibitory effect argued that the inhibition was probably not due to an indirect effect of butyrate on cell cycle kinetics. Moreover, inhibition of induction was observed with logarithmically dividing cells as well as with confluent cells (data not shown). This is consistent with the observation that hormone-induced Nuc-B displacement can occur under conditions in which DNA synthesis is inhibited (6) .
Butyrate also inhibited the induction of v-Ha-ras transcripts from pm23 episomes in 1361.5 cells (Fig. 4A) . Episome pm23 differs from pml8 in that pm23 contains an SV40 t-antigen splice site and early-region polyadenylylation site inserted downstream of the v-Ha-ras coding sequence, resulting in a predominant single transcript (see Fig. 1 ). Under these conditions butyrate had no effect on constitutive /8-actin transcripts (Fig. 4B) . Butyrate also inhibited hormoneinduced chloramphenicol acetyltransferase (CAT) activity from stable LTR-CAT episomes in 1471.1 cells (data not shown), demonstrating that the inhibitory activity of butyrate is independent of the reporter in the episome construct.
The butyrate to inhibit glucocorticoid induction of transcription from episomal constructs could be due to inactivation of a required transcription factor such as the glucocorticoid receptor. To determine whether butyrate affects the amount of receptor or its hormone binding affinity, cytosols were prepared from 904.13 cells after treatment with buffer or butyrate for 12 hr, and steroid binding was assayed by charcoaldextran adsorption under equilibrium binding conditions. Scatchard transformation of binding data from four experiments yielded a Bma, of 541 and 445 fmol/mg of protein and a KD of 2.1 nM and 0.95 nM for untreated and butyratetreated cells, respectively. This small change in receptor number would not be expected to significantly affect the level of induction, as confirmed below.
It is conceivable that butyrate alters the transcriptional activation activity of the receptor or of some other soluble factor that is necessary for transactivation of the MMTV promoter. For example, an intact NF1 binding site is required for efficient activation of the MMTV LTR by glucocorticoid in transient transfection assays and in stably transfected cell lines (34) (35) (36) (37) , and, therefore, an inhibitory effect of butyrate on NF1 activity would certainly explain the inhibition of induction. To test these possibilities, 904.13 cells were transfected with a full-length MMTV LTR-luciferase gene construct (pLTR-luc) or with a Rous sarcoma virus promoterluciferase gene construct (pRSV-luc) and then were treated with buffer or butyrate for 12 hr, followed by induction with TA for 4 hr. Cell lysates were assayed for luciferase activity. .13) were transfected with pLTR-luc or pRSV-luc by the calcium phosphate method and were then treated with buffer or 10 mM butyrate for 12 hr, followed by 100 nM TA or vehicle for 4 hr. Cells were harvested, lysates were prepared by freeze-thawing, and luciferase activity was assayed. The data represent an average of two experiments with triplicate samples for each condition. The luciferase activity measured for pLTR-luc-transfected cells was normalized by the amount of activity in pRSV-luc-transfected cells and is expressed as percent of pRSV-luc activity.
undergo receptor-mediated activation. Two 
